Close Menu

North America

Within the KiCS study researchers found targetable mutations in more than half of the kids, but few actually received drugs based on those molecular markers.

The drugmaker has partnered with Inspire and others to find study participants who have a genetic resilience to lung cancer.

The funds will support continued growth in precision oncology, new product development, and new initiatives in the clinical trial and biopharmaceutical markets.

The company also acquired DNA methylation analysis firm Base Genomics for $410 million and said it plans to raise $869 million in a direct stock offering.

FoundationOne Liquid CDx can now be used as a companion diagnostic for therapies to treat advanced ovarian, breast, and non-small cell lung cancer.

The test analyzes substitutions, insertion and deletion alterations, and copy number alterations in 324 genes, along with some genomic signatures in solid tumors.

Researchers showed benefit from chemotherapy in patients classified as high risk by the test, independent of their EGFR mutation status.

The agency issued a new draft decision memo, outlining various criteria it intends to apply when determining coverage for current and future blood-based CRC screening tests.

Researchers are continuing to collect data on economic, racial, and other factors that could be addressed to make precision medicine access more equitable.

The study identified multiple clusters of engineered natural killer T cells based on RNA-seq and found that they could be effective against the disease.

Pages